Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Aspen eyes Serum Institute model as it seeks licence to make J&J vaccine

09/02/2021 | 07:35am EDT

JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson & Johnson's (J&J) COVID-19 vaccine, Aspen Chief Executive Stephen Saad said on Thursday.

"At the moment, J&J could take all the product we make because it's their product, and sell it to Europe, for example, sell it to the U.S. or Korea, wherever they choose to. We have no say in that," he told Reuters.

"It's like Serum where they get the licences to manufacture. It's not a foreign model and it's very exciting," he said on the licensing talks.

(Reporting by Promit Mukherjee; Editing by Edmund Blair)


ę Reuters 2021
Latest news "Economy & Forex"
10:33aMARIA MARTINEZ : U.S. Mid-Atlantic Manufacturing Activity Strengthened in October -- Richmond Fed
DJ
10:32aBT strengthens bid defenses with Robey Warshaw hire
RE
10:30aIndia targets major global firms for local battery manufacturing - sources
RE
10:17aIndian court restrains Invesco from calling shareholders meeting in win for Zee
RE
10:12aU.S. consumer confidence unexpectedly rebounds in October
RE
10:02aChina's Modern Land misses bond payment; property shares drop
RE
09:59aSibanye Stillwater agrees $1 billion deal for nickel, copper mines in Brazil
RE
09:40aWall Street in Riyadh sees lingering inflation, oil hitting $100
RE
09:36aComputer mouse maker Logitech hit by supply chain problems
RE
09:35aGM to resume limited production at EV plant in Michigan
RE
Latest news "Economy & Forex"